Discussion of Veru Bearish Report Series pt. 2 by White Diamond Research

<p><em>Episode 207: </em>In this screen-share, Adam Gefvert, the head analyst from White Diamond Reseach goes over the latest part of a series of short reports unveiling the many problems of Veru Pharma. [<b>NASDAQ: VERU</b>]<br/><br/>Full Short Report: https://whitediamondresearch.com/research/part-2-new-red-flags-emerge-from-verus-phase-3-covid-trial-suggesting-an-fda-rejection-is-likely/ <br/><br/>Social media<br/><b><em>David Capablanca<br/></em></b>Twitter: <a href='https://twitter.com/reverse_long'><b>reverse_long</b></a><br/>Instagram: <a href='https://www.instagram.com/reverselong/'><b>reverselong</b></a></p>